Glomerulonephritis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
{| class="wikitable" | {| class="wikitable" | ||
!Glomerulonephritis | ! rowspan="2" |Glomerulonephritis | ||
!Sub-entity | ! rowspan="2" |Sub-entity | ||
!Causes and associations | ! rowspan="2" |Causes and associations | ||
!History and symtoms | ! colspan="7" |History and symtoms | ||
!Nephrotic features | ! rowspan="2" |Nephrotic features | ||
!Nephritic features | ! rowspan="2" |Nephritic features | ||
!ANCA | ! rowspan="2" |ANCA | ||
!Anti-glomerular basement membrane antibody (Anti-GBM antibody) | ! rowspan="2" |Anti-glomerular basement membrane antibody (Anti-GBM antibody) | ||
!Immune complex formation | ! rowspan="2" |Immune complex formation | ||
!Light microscope | ! rowspan="2" |Light microscope | ||
!Electron microscope | ! rowspan="2" |Electron microscope | ||
!Immunoflourescence pattern | ! rowspan="2" |Immunoflourescence pattern | ||
|- | |||
!History | |||
!Pitting edema | |||
!Hemeturia (Gross or microscopic) | |||
!Hypertension | |||
!Hemoptysis | |||
!Oliguria | |||
!Peri-orbital edema | |||
|- | |- | ||
! rowspan="3" |Non-proliferative | ! rowspan="3" |Non-proliferative | ||
Line 33: | Line 41: | ||
* Pitting edema | * Pitting edema | ||
* Hyperlipidemia and hyper colesterolemia | * Hyperlipidemia and hyper colesterolemia | ||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
!+ | !+ | ||
!- | !- | ||
Line 56: | Line 70: | ||
* Pitting edema | * Pitting edema | ||
* Hyperlipidemia and hypercolesterolemia | * Hyperlipidemia and hypercolesterolemia | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 77: | Line 97: | ||
* Pitting edema | * Pitting edema | ||
* Hyperlipidemia and hypercolesterolemia | * Hyperlipidemia and hypercolesterolemia | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 100: | Line 126: | ||
* Periorbital edema | * Periorbital edema | ||
* Hypertension | * Hypertension | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 121: | Line 153: | ||
* Periorbital edema | * Periorbital edema | ||
* Hypertension | * Hypertension | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 141: | Line 179: | ||
* Periorbital edema | * Periorbital edema | ||
* Hypertension | * Hypertension | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 165: | Line 209: | ||
* Hypertension | * Hypertension | ||
* Peripheral neuropathy | * Peripheral neuropathy | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 187: | Line 237: | ||
* Hypertension | * Hypertension | ||
* Peripheral neuropathy | * Peripheral neuropathy | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 206: | Line 262: | ||
* Periorbital edema | * Periorbital edema | ||
* Hypertension | * Hypertension | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
Line 226: | Line 288: | ||
* Periorbital edema | * Periorbital edema | ||
* Hypertension | * Hypertension | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> |
Revision as of 13:51, 11 April 2018
Glomerulonephritis Main page |
|
---|
Overview
Differential Diagnosis
Glomerulonephritis | Sub-entity | Causes and associations | History and symtoms | Nephrotic features | Nephritic features | ANCA | Anti-glomerular basement membrane antibody (Anti-GBM antibody) | Immune complex formation | Light microscope | Electron microscope | Immunoflourescence pattern | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
History | Pitting edema | Hemeturia (Gross or microscopic) | Hypertension | Hemoptysis | Oliguria | Peri-orbital edema | |||||||||||
Non-proliferative | Minimal change disease |
|
|
+ | - | - | - | - |
|
Fusion of podocytes | - | ||||||
Focal segmental glomerulosclerosis |
|
|
+ | - | - | - | - |
|
|
||||||||
Membranous glomerulonephritis |
|
|
+ | - | - | - | + |
|
|
||||||||
Proliferative | IgA nephropathy |
|
|
- | + | - | - | + |
|
|
|||||||
Rapidly progressive glomerulonephritis |
|
|
- | + | - | + | + (Linear) | ||||||||||
|
|
- | + | - | - | + |
|
|
+ (granular) | ||||||||
|
|
- | + | + (C-ANCA) | - | - |
|
|
|||||||||
|
|
- | + |
+ (C-ANCA) |
- | ||||||||||||
|
|
- | + |
+ (P-ANCA) |
- | ||||||||||||
Membranoproliferative glomerulonephritis |
|
|
+ | - | - | - |